Filter posts

SEC Proposes Targeted Regulatory Relief for Certain Small Public Companies from Sarbanes-Oxley 404(b...

In a much-anticipated move, the Securities and Exchange Commission (SEC) recently proposed a rule to …

Women Who are Changing the Game in Biotech

Fighting for diversity in the workplace is more than a “feel good” or “the right …

USDA Report: China’s Biotech Crop Approval Process Becoming More Unpredictable and Burdensome

Across the United States, farmers use biotech crops to address production challenges – such as …

With an Air of Optimism, #BIOCEO19 Concludes

Despite considerable pressure directed squarely at biotech innovators from politicians of every stripe, biotech executives …

Meet Kallyope’s Nancy Thornberry, Fireside Chat Speaker at #BIOCEO19

Biotech startups come in all shapes, sizes and approaches but have one thing in common: …

Using Decision Science for Negotiations: Getting to Win-Win

New medicines often progress from idea to regulatory approval through collaborative licensing agreements or acquisition.  …

Interactive Map Displays Strength of Industry’s National Footprint

BIO’s biennial economic development and jobs report focuses on the economic progress and national footprint …

BIO Celebrates 300 Biotech IPOs since Enactment of the JOBS Act

The biotech industry recently realized its 300th IPO since the Jumpstart Our Business Startups (JOBS) …

New Member Benefit: Online Marketplace for Custom Scientific Research Services and Products

BIO’s member companies in the pharmaceutical, life sciences, chemicals, and biotechnology sectors routinely and strategically …

#MakeHistory: Highlighting History I China

Venture capital investment in US biotech companies has skyrocketed as Chinese investors continue to fuel …